Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers

References

• Boice JD. Ionizing radiation. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. New York, NY: Oxford University Press; 2006. pp 259–293.
   Google Scholar
• United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and effects of ionizing radiation. Vol. II: Effects. New York: United Nations; 2000.
   Google Scholar
• Preston DL, Kusumi S, Tomonaga M, et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res 1994;137 S68–S97; erratum Radiat Res 1994;139:129.
   PubMed Web of Science ®Google Scholar
• Richardson D, Sugiyama H, Nishi N, et al. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950-2000. Radiat Res 2009;172:368–382.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Schull WJ, Kato H. Cancer risk among atomic bomb survivors. The RERF Life Span Study. Radiation Effects Research Foundation. JAMA 1990;264:601–604.
   Google Scholar
• Beral V, Inskip H, Fraser P, et al. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J (Clin Res Ed) 1985;291:440–447.
   PubMed Web of Science ®Google Scholar
• Carpenter L, Higgins C, Douglas A, et al. Combined analysis of mortality in three United Kingdom nuclear industry workforces, 1946-1988. Radiat Res 1994;138:224–238.
   PubMed Web of Science ®Google Scholar
• Richardson DB, Sugiyama H, Wing S, et al. Positive associations between ionizing radiation and lymphoma mortality among men. Am J Epidemiol 2009;169:969–976.
   PubMed Web of Science ®Google Scholar
• Cardis E, Gilbert ES, Carpenter L, et al. Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 1995;142: 117–132.
   PubMed Web of Science ®Google Scholar
• Gilbert ES, Omohundro E, Buchanan JA, et al. Mortality of workers at the Hanford site: 1945-1986. Health Phys 1993;64:577–590.
   PubMed Web of Science ®Google Scholar
• Kendall GM, Muirhead CR, MacGibbon BH, et al. Mortality and occupational exposure to radiation: first analysis of the National Registry for Radiation Workers. BMJ 1992;304:220–225.
   PubMed Web of Science ®Google Scholar
• Mohan AK, Hauptmann M, Freedman DM, et al. Cancer and other causes of mortality among radiologic technologists in the United States. Int J Cancer 2003;103:259–267.
   PubMed Web of Science ®Google Scholar
• Wang JX, Zhang LA, Li BX, et al. Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995. Health Phys 2002;82:455–466.
   PubMed Web of Science ®Google Scholar
• Eheman CR, Tolbert PE, Coates RJ, et al. Case-control assessment of the association between non-Hodgkin's lymphoma and occupational radiation with doses assessed using a job exposure matrix. Am J Ind Med 2000;38:19–27.
   PubMed Web of Science ®Google Scholar
• Darby SC, Doll R, Gill SK, et al. Long term mortality after a single treatment course of x-rays in patients treated for ankylosing spondylitis. Br J Cancer 1987;55:179–190.
   PubMed Web of Science ®Google Scholar
• Weiss HA, Darby SC, Doll R. Cancer mortality following x-ray treatment for ankylosing spondylitis. Int J Cancer 1994;142:1–11.
   Google Scholar
• Tucker MA, Coleman CN, Cox RS, et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988;318:76–81.
   PubMed Web of Science ®Google Scholar
• Boice JD Jr, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res 1988;116:3–55.
   PubMed Web of Science ®Google Scholar
• Ron E, Boice DJ Jr, Hamburger S, et al. Mortality following radiation treatment for infertility of hormonal origin or amenorrhoea. Int J Epidemiol 1994;23:1165–1173.
   PubMed Web of Science ®Google Scholar
• Carr ZA, Kleinerman RA, Stovall M, et al. Malignant neoplasms after radiation therapy for peptic ulcer. Radiat Res 2002;157: 668–677.
   PubMed Web of Science ®Google Scholar
• Dores G, Metayer C, Curtis RE, et al. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years. J Clin Oncol 2002;20:3483–3494.
   Web of Science ®Google Scholar
• Wagoner JK. Leukemia and other malignancies following radiation therapy for gynecological disorders. In: Boice JD Jr, Fraumeni JF Jr, editors. Radiation carcinogenesis: epidemiology and biological significance. New York: Raven Press; 1984. pp 153–159.
   Google Scholar
• Chaturvedi AK, Engels EA, Gilbert ES, et al. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. J Natl Cancer Inst 2007;99:1634–1643.
   PubMed Web of Science ®Google Scholar
• Curtis RE, Hoover RN, Kleinerman RA, et al. Second cancer following cancer of the female genital system in Connecticut, 1935-92. Natl Cancer Inst Monogr 1985;68:113–137.
   PubMedGoogle Scholar
• Inskip PD, Monson RR, Wagoner JK, et al. Leukemia following radiotherapy for uterine bleeding. Radiat Res 1990;122:107–119.
   PubMed Web of Science ®Google Scholar
• Inskip PD, Kleinerman RA, Stovall M, et al. Leukemia, lymphoma, and multiple myeloma after pelvic radiotherapy for benign disease. Radiat Res 1993;135:108–124.
   PubMed Web of Science ®Google Scholar
• Kleinerman RA, Boice JD Jr, Storm HH, et al. Second primary cancer after treatment for cervical cancer. An international cancer registry study. Cancer 1995;76:442–452.
   PubMedGoogle Scholar
• Darby SC, Reeves G, Key T, et al. Mortality in a cohort of women given x-ray therapy for metropathia haemorrhagica. Int J Cancer 1994;56:793–801.
   PubMed Web of Science ®Google Scholar
• Damber L, Larsson LG, Johansson L, et al. A cohort study with regard to the risk of haematological malignancies in patients treated with x-rays for benign lesions in the locomotor system. I. Epidemiological analyses. Acta Oncol 1995;34:713–719.
   PubMed Web of Science ®Google Scholar
• Davis FG, Boice JD Jr, Hrubec Z, et al. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 1989;49:6130–6136.
   PubMed Web of Science ®Google Scholar
• Boice JD Jr, Morin MM, Glass AG, et al. Diagnostic x-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA 1991;265:1290–1294.
   PubMed Web of Science ®Google Scholar
• Surveillance Research Program, National Cancer Institute SEER *Stat software version 7.0.2. Available from: www.seer.cancer.gov/seerstat
   Google Scholar
• National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112–2135.
   PubMed Web of Science ®Google Scholar
• Fritz A, Percy C, Jack A, et al., editors. International Classification of Diseases for Oncology. 3rd ed.Geneva: World Health Organization; 2000.
   Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695–708.
   PubMed Web of Science ®Google Scholar
• Fraumeni JF Jr, Curtis RE, Edwards BK, et al. Introduction. In: Curtis RE, Freedman DM, Ron E, et al., editors. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. National Cancer Institute NIH Publ No. 05-5302. Bethesda, MD: NCI; 2006. pp. 1–7.
   Google Scholar
• Curtis RE, Ries LAG. Methods. In: Curtis RE, Freedman DM, Ron E, et al., editors. New malignancies among cancer survivors: SEER cancer registries, 1973-2000. National Cancer Institute NIH Publ No. 05-5302. Bethesda, MD: NCI; 2006. p. 14.
   Google Scholar
• Yasui Y, Liu Y, Neglia JP, et al. A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers. Am J Epidemiol 2003;158:1108–1113.
   PubMed Web of Science ®Google Scholar
• Preston DL, Lubin JL, Pierce DA, McConney ME. Epicure User’s Guide. Hirosoft International Corporation, Seattle, USA. 1993.
   Google Scholar
• Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–1392.
   PubMed Web of Science ®Google Scholar
• Schaue D, McBride WH. Links between innate immunity and normal tissue radiobiology. Radiat Res 2010;173:406–417.
   PubMed Web of Science ®Google Scholar
• Clinical response of normal tissues. In: Hall EJ, Giaccia AJ, editors. Radiobiology for the radiologist. Philadelphia, PA: Lippincott Williams & Wilkins; 2006. pp 327–348.
   Google Scholar
• Muller AMS, Ihorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005;84:1–12.
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007;370:59–67.
   PubMed Web of Science ®Google Scholar
• Kusunoki Y, Hayashi T. Long-lasting alterations of the immune system by ionizing radiation exposure: implications for disease development among atomic bomb survivors. Int J Radiat Biol 2008; 84:1–14.
   PubMed Web of Science ®Google Scholar
• Jagsi R, Abrahamse P, Hawley ST, et al. Underascertainment of radiotherapy receipt in Surveillence, Epidemiology, and End Results registry data. Cancer 2012;118:333–341.
   PubMed Web of Science ®Google Scholar
• Krishnan B, Morgan GJ. Non-Hodgkin lymphoma secondary to cancer chemotherapy. Cancer Epidemiol Biomarkers Prev 2007; 16:377–380.
   PubMed Web of Science ®Google Scholar